Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma.

Trial Profile

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 25 Nov 2014

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
    • 27 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
    • 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top